The aims of the study are:
- to assess the safety profile of danavorexton when it is administered with anesthetics.
- to learn what effect danavorexton has on anesthetized adults.
On Day 1, participants will receive a single intravenous (IV) infusion of danavorexton or a
placebo after participants have been anesthetized for about 40 minutes. Clinic doctors will
arrange a follow-up visit by phone or video on Day 7.